A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine

Masanori Sawada, Daisuke Sugiyama, Takenobu Nii, Katsuhiro Konno, Hardy T.S. Kagimoto

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Regenerative medicine mediated by the transplantation of somatic stem cells and functional cells derived from induced pluripotent stem cells has great potential in the treatment of currently incurable diseases and thus has attracted significant public attention. To put this into practice, several functional cell lines were developed and laws regarding regenerative medicine were put in force in Japan. In this report, we introduce recent efforts of a bioventure company with special attention to the case of Healios K.K.

Original languageEnglish
Pages (from-to)1801-1806
Number of pages6
JournalClinical Therapeutics
Volume40
Issue number11
DOIs
Publication statusPublished - Nov 2018

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine'. Together they form a unique fingerprint.

Cite this